Ecopipam

Ecopipam · Emalex Biosciences Inc.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Ecopipam, covering 2013-02-12 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist [Phase 1, Phase 2]